2型糖尿病心血管疾病危险因素及治疗
Risk Factors and Treatment of Cardiovascular Disease in Type 2 Diabetes
DOI: 10.12677/acm.2025.151242, PDF,    科研立项经费支持
作者: 周欣雨：西安医学院研究生院，陕西 西安；郑靖威, 李 科, 荣 誉：西安市常见老龄疾病防治重点实验室、慢病防治研究与转化中心、基础与转化医学研究所，西安医学院，陕西 西安；李雪萍：西安市常见老龄疾病防治重点实验室、慢病防治研究与转化中心、基础与转化医学研究所，西安医学院，陕西 西安；西安医学院临床医学院，陕西 西安；宋 梅, 周 韵：西安医学院临床医学院，陕西 西安；郭 剑：陕西省人民医院内分泌科，陕西 西安
关键词: 2型糖尿病；心血管疾病；危险因素；血糖管理；血脂调节；血压控制；抗血小板治疗；Type 2 Diabetes； Cardiovascular Disease； Risk Factors； Blood Sugar Management； Lipid Regulation； Blood Pressure Control； Antiplatelet Therapy
摘要: 近年来全球糖尿病患者数量增长迅速，心血管疾病已成为2型糖尿病患者的主要死亡原因。因此，对于糖尿病患者来说，重视心血管疾病的预防和管理至关重要。心血管疾病的危险因素是多方面的，包括年龄、性别、吸烟、脂代谢紊乱、高血压及肥胖等。这些因素可能单独或共同作用，增加心血管疾病的风险。针对2型糖尿病心血管疾病危险因素的综合管理涉及多个方面，包括血糖管理、血压控制、血脂调节、抗血小板治疗以及生活方式管理，通过综合考虑和控制相关风险因素，可以更有效地降低心血管疾病的风险。本文将对上述危险因素及相关治疗措施进行综述，以期为2型糖尿病心血管疾病的发生与发展提供参考依据。
Abstract: In recent years, the number of people with diabetes worldwide has grown rapidly, and cardiovascular diseases have become the leading cause of death for patients with type 2 diabetes. Therefore, it is of utmost importance for diabetic patients to focus on the prevention and management of cardiovascular diseases. The risk factors for cardiovascular diseases are multifaceted, including age, gender, smoking, lipid metabolism disorders, hypertension, and obesity, etc. These factors may act individually or in combination, increasing the risk of cardiovascular diseases. Comprehensive management of the risk factors for cardiovascular diseases in type 2 diabetes involves various aspects, including blood sugar management, blood pressure control, lipid regulation, antiplatelet therapy, and lifestyle management. By considering and controlling these risk factors in a holistic manner, the risk of cardiovascular diseases can be more effectively reduced. This paper will review the aforementioned risk factors and related treatment measures, aiming to provide a reference for the occurrence and progression of cardiovascular diseases in patients with type 2 diabetes.
文章引用：周欣雨, 郑靖威, 李雪萍, 宋梅, 郭剑, 周韵, 李科, 荣誉. 2型糖尿病心血管疾病危险因素及治疗[J]. 临床医学进展, 2025, 15(1): 1813-1821. https://doi.org/10.12677/acm.2025.151242

参考文献

[1] Ojo, O. (2019) Dietary Intake and Type 2 Diabetes. Nutrients, 11, Article 2177. [Google Scholar] [CrossRef] [PubMed]
[2] 中国居民营养与慢性病状况报告[J]. 营养学报, 2020, 42(6): 521.
[3] 杨文英. 中国糖尿病的流行特点及变化趋势[J]. 中国科学: 生命科学, 2018, 48(8): 812-819.
[4] Schmidt, A.M. (2019) Diabetes Mellitus and Cardiovascular Disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 39, 558-568. [Google Scholar] [CrossRef] [PubMed]
[5] 国家心血管病中心, 中国心血管健康与疾病报告编写组, 胡盛寿. 中国心血管健康与疾病报告2023概要[J]. 中国循环杂志, 2024, 39(7): 625-660.
[6] Wong, N.D. and Sattar, N. (2023) Cardiovascular Risk in Diabetes Mellitus: Epidemiology, Assessment and Prevention. Nature Reviews Cardiology, 20, 685-695. [Google Scholar] [CrossRef] [PubMed]
[7] Marx, N., Federici, M., Schütt, K., Müller-Wieland, D., Ajjan, R.A., Antunes, M.J., et al. (2023) 2023 ESC Guidelines for the Management of Cardiovascular Disease in Patients with Diabetes. European Heart Journal, 44, 4043-4140.
[8] Sattar, N., Rawshani, A., Franzén, S., Rawshani, A., Svensson, A., Rosengren, A., et al. (2019) Age at Diagnosis of Type 2 Diabetes Mellitus and Associations with Cardiovascular and Mortality Risks. Circulation, 139, 2228-2237. [Google Scholar] [CrossRef] [PubMed]
[9] Huo, X., Gao, L., Guo, L., Xu, W., Wang, W., Zhi, X., et al. (2016) Risk of Non-Fatal Cardiovascular Diseases in Early-Onset versus Late-Onset Type 2 Diabetes in China: A Cross-Sectional Study. The Lancet Diabetes & Endocrinology, 4, 115-124. [Google Scholar] [CrossRef] [PubMed]
[10] Chen, F., Yu, L., Xie, S., Li, Z., Deng, R., Jin, X., et al. (2023) Cardiovascular Disease Risk in Early‐Onset vs Late‐onset Type 2 Diabetes in China: A Population‐Based Cross‐Sectional Study. Journal of Diabetes, 16, e13493. [Google Scholar] [CrossRef] [PubMed]
[11] Huxley, R., Barzi, F. and Woodward, M. (2005) Excess Risk of Fatal Coronary Heart Disease Associated with Diabetes in Men and Women: Meta-Analysis of 37 Prospective Cohort Studies. BMJ, 332, 73-78. [Google Scholar] [CrossRef] [PubMed]
[12] Shah, A.D., Langenberg, C., Rapsomaniki, E., Denaxas, S., Pujades-Rodriguez, M., Gale, C.P., et al. (2015) Type 2 Diabetes and Incidence of Cardiovascular Diseases: A Cohort Study in 1.9 Million People. The Lancet Diabetes & Endocrinology, 3, 105-113. [Google Scholar] [CrossRef] [PubMed]
[13] Wright, A.K., Kontopantelis, E., Emsley, R., Buchan, I., Mamas, M.A., Sattar, N., et al. (2019) Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus. Circulation, 139, 2742-2753. [Google Scholar] [CrossRef] [PubMed]
[14] Bays, H.E., Toth, P.P., Kris-Etherton, P.M., Abate, N., Aronne, L.J., Brown, W.V., et al. (2013) Obesity, Adiposity, and Dyslipidemia: A Consensus Statement from the National Lipid Association. Journal of Clinical Lipidology, 7, 304-383. [Google Scholar] [CrossRef] [PubMed]
[15] Regensteiner, J.G., Golden, S., Huebschmann, A.G., Barrett-Connor, E., Chang, A.Y., Chyun, D., et al. (2015) Sex Differences in the Cardiovascular Consequences of Diabetes Mellitus: A Scientific Statement From the American Heart Association. Circulation, 132, 2424-2447. [Google Scholar] [CrossRef] [PubMed]
[16] Stamataki, K.E., Spina, J., Rangou, D.B., Chlouverakis, C.S. and Piaditis, G.P. (1996) Ovarian Function in Women with Non‐Insulin Dependent Diabetes Mellitus. Clinical Endocrinology, 45, 615-629. [Google Scholar] [CrossRef] [PubMed]
[17] Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C.N., Chieffo, A., Figtree, G.A., et al. (2021) The Lancet Women and Cardiovascular Disease Commission: Reducing the Global Burden by 2030. The Lancet, 397, 2385-2438. [Google Scholar] [CrossRef] [PubMed]
[18] 汤云霞, 黄翯. 女性心血管疾病现状及性别特异性危险因素分析[J]. 心电与循环, 2024, 43(6): 544-549.
[19] Hackshaw, A., Morris, J.K., Boniface, S., Tang, J.-L. and Milenković, D. (2018) Low Cigarette Consumption and Risk of Coronary Heart Disease and Stroke: Meta-Analysis of 141 Cohort Studies in 55 Study Reports. BMJ, 361, k1611. [Google Scholar] [CrossRef] [PubMed]
[20] Pan, A., Wang, Y., Talaei, M. and Hu, F.B. (2015) Relation of Smoking with Total Mortality and Cardiovascular Events among Patients with Diabetes Mellitus: A Meta-Analysis and Systematic Review. Circulation, 132, 1795-1804. [Google Scholar] [CrossRef] [PubMed]
[21] Barengo, N.C., Teuschl, Y., Moltchanov, V., Laatikainen, T., Jousilahti, P. and Tuomilehto, J. (2017) Coronary Heart Disease Incidence and Mortality, and All-Cause Mortality among Diabetic and Non-Diabetic People According to Their Smoking Behavior in Finland. Tobacco Induced Diseases, 15, Article 12. [Google Scholar] [CrossRef] [PubMed]
[22] Jeong, S., Yoo, J.E., Park, J., Jung, W., Lee, K.N., Han, K., et al. (2023) Smoking Behavior Change and Risk of Cardiovascular Disease Incidence and Mortality in Patients with Type 2 Diabetes Mellitus. Cardiovascular Diabetology, 22, Article No. 193. [Google Scholar] [CrossRef] [PubMed]
[23] Zhang, J., Cui, R., Qi, Z., Zhou, L., Li, Z. and Li, Q. (2016) Evaluation of Serum Lipid Profile, Body Mass Index, and Waistline in Chinese Patients with Type 2 Diabetes Mellitus. Clinical Interventions in Aging, 11, 445-452. [Google Scholar] [CrossRef] [PubMed]
[24] Yan, L., Xu, M.T., Yuan, L., Chen, B., Xu, Z.R., Guo, Q.H., et al. (2016) Prevalence of Dyslipidemia and Its Control in Type 2 Diabetes: A Multicenter Study in Endocrinology Clinics of China. Journal of Clinical Lipidology, 10, 150-160. [Google Scholar] [CrossRef] [PubMed]
[25] 肖扬, 于碧莲. 糖尿病患者血脂管理中国专家共识(2024版) [J]. 中国循环杂志, 2024, 39(4): 322-341.
[26] Ji, L., Hu, D., Pan, C., Weng, J., Huo, Y., Ma, C., et al. (2013) Primacy of the 3B Approach to Control Risk Factors for Cardiovascular Disease in Type 2 Diabetes Patients. The American Journal of Medicine, 126, 925.e11-925.e22. [Google Scholar] [CrossRef] [PubMed]
[27] 葛均波, 翁建平, 曾强. 2型糖尿病患者泛血管疾病风险评估与管理中国专家共识(2022版) [J]. 中国循环杂志, 2022, 37(10): 974-990.
[28] 王增武, 刘静, 李建军, 吴娜琼, 陆国平, 陈桢玥, 赵冬, 赵水平, 高润霖, 郭远林, 等. 中国血脂管理指南(2023年) [J]. 中国循环杂志, 2023, 38(3): 237-271.
[29] Ohishi, M. (2018) Hypertension with Diabetes Mellitus: Physiology and Pathology. Hypertension Research, 41, 389-393. [Google Scholar] [CrossRef] [PubMed]
[30] Widimský, J. (2016) The SPRINT Research. A Randomized Trial of Intensive versus Standard Blood-Pressure Control. Vnitrní Lékařství, 62, 44-47.
[31] He, J., Gu, D., Chen, J., Wu, X., Kelly, T.N., Huang, J., et al. (2009) Premature Deaths Attributable to Blood Pressure in China: A Prospective Cohort Study. The Lancet, 374, 1765-1772. [Google Scholar] [CrossRef] [PubMed]
[32] Cao, X., Zhao, Z., Kang, Y., Tian, Y., Song, Y., Wang, L., et al. (2022) The Burden of Cardiovascular Disease Attributable to High Systolic Blood Pressure across China, 2005-18: A Population-Based Study. The Lancet Public Health, 7, e1027-e1040. [Google Scholar] [CrossRef] [PubMed]
[33] Zhang, Y., Li, Y., Dong, Y., Wu, Y., Bian, R., Li, J., et al. (2019) A Nationwide Assessment of Blood Pressure Control and the Associated Factors in Chinese Type 2 Diabetes Mellitus Patients. The Journal of Clinical Hypertension, 21, 1654-1663. [Google Scholar] [CrossRef] [PubMed]
[34] Wang, C. (2014) Influence of Overweight, Obesity and Major Risk Factors on the Incidence of Diabetes in Chinese Adults. Doctor Thesis, Peking Union Medical College.
[35] Piché, M., Tchernof, A. and Després, J. (2020) Obesity Phenotypes, Diabetes, and Cardiovascular Diseases. Circulation Research, 126, 1477-1500. [Google Scholar] [CrossRef] [PubMed]
[36] Li, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E.W., et al. (2014) Cardiovascular Mortality, All-Cause Mortality, and Diabetes Incidence after Lifestyle Intervention for People with Impaired Glucose Tolerance in the Da Qing Diabetes Prevention Study: A 23-Year Follow-Up Study. The Lancet Diabetes & Endocrinology, 2, 474-480. [Google Scholar] [CrossRef] [PubMed]
[37] Iona, A., Bragg, F., Guo, Y., Yang, L., Chen, Y., Pei, P., et al. (2022) Adiposity and Risks of Vascular and Non-Vascular Mortality among Chinese Adults with Type 2 Diabetes: A 10-Year Prospective Study. BMJ Open Diabetes Research & Care, 10, e002489. [Google Scholar] [CrossRef] [PubMed]
[38] Huang, Z., Zhuang, X., Huang, R., Liu, M., Xu, X., Fan, Z., et al. (2024) Physical Activity and Weight Loss among Adults with Type 2 Diabetes and Overweight or Obesity: A Post Hoc Analysis of the Look AHEAD Trial. JAMA Network Open, 7, e240219. [Google Scholar] [CrossRef] [PubMed]
[39] Unick, J.L., Beavers, D., Bond, D.S., Clark, J.M., Jakicic, J.M., Kitabchi, A.E., et al. (2013) The Long-Term Effectiveness of a Lifestyle Intervention in Severely Obese Individuals. The American Journal of Medicine, 126, 236-242.E2. [Google Scholar] [CrossRef] [PubMed]
[40] Hong, T., Yan, Z., Li, L., Tang, W., Qi, L., Ye, J., et al. (2022) The Prevalence of Cardiovascular Disease in Adults with Type 2 Diabetes in China: Results from the Cross-Sectional CAPTURE Study. Diabetes Therapy, 13, 969-981. [Google Scholar] [CrossRef] [PubMed]
[41] 刘靖, 周翔海. 冠心病合并2型糖尿病患者的血糖管理专家共识[J]. 中国循环杂志, 2024, 39(4): 342-352.
[42] Ji, L. and Chen, Y. (2024) Consensus on Glycemic Management for Patients with Coronary Heart Disease and Type 2 Diabetes. Journal of Geriatric Cardiology, 21, 689-702. [Google Scholar] [CrossRef] [PubMed]
[43] ElSayed, N.A., Aleppo, G., Bannuru, R.R., Bruemmer, D., Collins, B.S., Ekhlaspour, L., et al. (2023) Pharmacologic Approaches to Glycemic Treatment: standards of Care in Diabetes—2024. Diabetes Care, 47, S158-S178. [Google Scholar] [CrossRef] [PubMed]
[44] 《中国老年型糖尿病防治临床指南》编写组. 中国老年2型糖尿病防治临床指南(2022年版) [J]. 中国糖尿病杂志, 2022, 30(1): 2-51.
[45] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (上) [J]. 中国实用内科杂志, 2021, 41(8): 668-695.
[46] 黄恺, 段宇辰. 胰高血糖素样肽-1受体激动剂防治成人2型糖尿病合并动脉粥样硬化性心血管疾病的中国专家共识[J]. 临床心血管病杂志, 2023, 39(9): 651-660.
[47] 司海娇, 肇丽梅, 蔡爽, 王可可, 王家鑫, 高飞, 刘慧霞, 孙鸣, 汪宇, 刘彤. 胰高血糖素样肽1受体激动剂类药物用药指导(2023版) [J]. 中国药房, 2023, 34(11): 1281-1292.
[48] 刘凤琪, 柴三葆, 赵厚宇, 刘佐相, 武珊珊, 杨智荣, 詹思延, 孙凤. 钠-葡萄糖共转运蛋白2抑制剂引起2型糖尿病患者尿路或生殖器感染风险的网状Meta分析[J]. 中华糖尿病杂志, 2022, 14(8): 799-808.
[49] Cholesterol Treatment Trialists’ (CTT) Collaboration (2010) Efficacy and Safety of More Intensive Lowering of LDL Cholesterol: A Meta-Analysis of Data from 170 000 Participants in 26 Randomised Trials. The Lancet, 376, 1670-1681. [Google Scholar] [CrossRef] [PubMed]
[50] 中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) (下) [J]. 中国实用内科杂志, 2021, 41(9): 757-784.
[51] Mansi, I.A., Chansard, M., Lingvay, I., Zhang, S., Halm, E.A. and Alvarez, C.A. (2021) Association of Statin Therapy Initiation with Diabetes Progression: A Retrospective Matched-Cohort Study. JAMA Internal Medicine, 181, 1562-1574. [Google Scholar] [CrossRef] [PubMed]
[52] Catalá-López, F., Macías Saint-Gerons, D., González-Bermejo, D., Rosano, G.M., Davis, B.R., Ridao, M., et al. (2016) Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses. PLOS Medicine, 13, e1001971. [Google Scholar] [CrossRef] [PubMed]
[53] Weber, M.A., Bakris, G.L., Jamerson, K., Weir, M., Kjeldsen, S.E., Devereux, R.B., et al. (2010) Cardiovascular Events during Differing Hypertension Therapies in Patients with Diabetes. Journal of the American College of Cardiology, 56, 77-85. [Google Scholar] [CrossRef] [PubMed]
[54] Bi, Y., Li, M., Liu, Y., Li, T., Lu, J., Duan, P., Xu, F., Dong, Q., Wang, A., Wang, T., et al. (2024) Intensive Blood-Pressure Control in Patients with Type 2 Diabetes. The New England Journal of Medicine. [Google Scholar] [CrossRef] 
[55] The ASCEND Study Collaborative Group (2018) Effects of Aspirin for Primary Prevention in Persons with Diabetes Mellitus. The New England Journal of Medicine, 379, 1529-1539. [Google Scholar] [CrossRef] 
[56] 黄恺, 曾天舒, 刘刚, 杨柳. 中国成人2型糖尿病及糖尿病前期患者动脉粥样硬化性心血管疾病预防与管理专家共识[J]. 中国糖尿病杂志, 2023, 31(9): 641-656.
[57] Liu, G., Li, Y., Hu, Y., Zong, G., Li, S., Rimm, E.B., et al. (2018) Influence of Lifestyle on Incident Cardiovascular Disease and Mortality in Patients with Diabetes Mellitus. Journal of the American College of Cardiology, 71, 2867-2876. [Google Scholar] [CrossRef] [PubMed]
[58] Kotseva, K. (2017) The EUROASPIRE Surveys: Lessons Learned in Cardiovascular Disease Prevention. Cardiovascular Diagnosis and Therapy, 7, 633-639. [Google Scholar] [CrossRef] [PubMed]
[59] 俞蔚, 丁芳, 张洁, 王爱红. 高血压、高血糖、高血脂基层健康管理规范[J]. 心脑血管病防治, 2024, 24(7): 1-14.

为你推荐